Erin Righetti

The teeming influx of life science industry folk in San Francisco during the second week of January represents the zenith of the 36th annual J.P. Morgan Healthcare Conference pilgrimage. Concurrent events add to the draw for the who’s who of life science investing, from industry leaders and emerging fast-growth companies, to investors, innovative technology creators and biotech. For those well versed in the conference circuit, you’ll recognize the madness as just par for the course during JPM Week.